{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:49:07Z","timestamp":1790336947543,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1378\/chest.14-0793","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T10:55:59Z","timestamp":1403002559000},"page":"449-475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":233,"title":["Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults"],"prefix":"10.1016","volume":"146","author":[{"given":"Darren B.","family":"Taichman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Ornelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold I.","family":"Palevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namita","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika B.","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence K.","family":"Trow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rex","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Gregory","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Badesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 25","key":"10.1378\/chest.14-0793_bib1","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1378\/chest.14-0793_bib2","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1378\/chest.06-2674","article-title":"Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines","volume":"131","author":"Badesch","year":"2007","journal-title":"Chest"},{"issue":"16","key":"10.1378\/chest.14-0793_bib3","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"issue":"suppl 25","key":"10.1378\/chest.14-0793_bib4","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1378\/chest.14-0793_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1378\/chest.14-0793_bib6","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1001\/jama.2011.597","article-title":"IOM sets out \u201cgold standard\u201d practices for creating guidelines, systematic reviews","volume":"305","author":"Kuehn","year":"2011","journal-title":"JAMA"},{"issue":"7","key":"10.1378\/chest.14-0793_bib7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0025-6196(11)60747-7","article-title":"Wide variation in clinicians' assessment of New York Heart Association\/World Health Organization FC in patients with pulmonary arterial hypertension","volume":"84","author":"Taichman","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1378\/chest.14-0793_bib8","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1378\/chest.12-1110","article-title":"Has the 6-min walk distance run its course?","volume":"142","author":"McLaughlin","year":"2012","journal-title":"Chest"},{"issue":"suppl 25","key":"10.1378\/chest.14-0793_bib9","doi-asserted-by":"crossref","first-page":"D73","DOI":"10.1016\/j.jacc.2013.10.034","article-title":"Treatment goals of pulmonary hypertension","volume":"62","author":"McLaughlin","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 25","key":"10.1378\/chest.14-0793_bib10","doi-asserted-by":"crossref","first-page":"D117","DOI":"10.1016\/j.jacc.2013.10.028","article-title":"Pediatric pulmonary hypertension","volume":"62","author":"Ivy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.14-0793_bib11","series-title":"Pulmonary Arterial Hypertension: Screening, Management, and Treatment","author":"McCrory","year":"2013"},{"key":"10.1378\/chest.14-0793_bib12","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"7454","key":"10.1378\/chest.14-0793_bib13","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"1","key":"10.1378\/chest.14-0793_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1378\/chest.129.1.174","article-title":"Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force","volume":"129","author":"Guyatt","year":"2006","journal-title":"Chest"},{"issue":"1","key":"10.1378\/chest.14-0793_bib15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.14-0824","article-title":"Methodologies for the development of CHEST guidelines and expert panel reports","volume":"146","author":"Lewis","year":"2014","journal-title":"Chest"},{"key":"10.1378\/chest.14-0793_bib16","series-title":"Consensus Methods: Characteristics and Guidelines for Use","author":"Fink","year":"1991"},{"key":"10.1378\/chest.14-0793_bib17","doi-asserted-by":"crossref","first-page":"a744","DOI":"10.1136\/bmj.a744","article-title":"Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive","volume":"337","author":"Jaeschke","year":"2008","journal-title":"BMJ"},{"key":"10.1378\/chest.14-0793_bib18","series-title":"Primary Pulmonary Hypertension: Executive Summary","author":"Rich","year":"1998"},{"issue":"5","key":"10.1378\/chest.14-0793_bib19","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0735-1097(91)90556-O","article-title":"High dose titration of calcium channel blocking agents for primary pulmonary hypertension: guidelines for short-term drug testing","volume":"18","author":"Rich","year":"1991","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1378\/chest.14-0793_bib20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0735-1097(98)00668-8","article-title":"Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing","volume":"33","author":"Atz","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1378\/chest.14-0793_bib21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/0002-9343(51)90020-4","article-title":"Primary pulmonary hypertension. I. Clinical and hemodynamic study","volume":"11","author":"Dresdale","year":"1951","journal-title":"Am J Med"},{"issue":"3","key":"10.1378\/chest.14-0793_bib22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0002-8703(58)90059-0","article-title":"Effects of tolazoline hydrochloride (priscoline) on circulatory dynamics of patients with pulmonary hypertension","volume":"55","author":"Rudolph","year":"1958","journal-title":"Am Heart J"},{"issue":"2","key":"10.1378\/chest.14-0793_bib23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1161\/01.CIR.66.2.334","article-title":"Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension","volume":"66","author":"Rubin","year":"1982","journal-title":"Circulation"},{"issue":"1","key":"10.1378\/chest.14-0793_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1378\/chest.107.1.54","article-title":"Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension","volume":"107","author":"Nootens","year":"1995","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.14-0793_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1378\/chest.14-0793_bib26","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"issue":"15","key":"10.1378\/chest.14-0793_bib27","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/eurheartj\/ehq170","article-title":"Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension","volume":"31","author":"Montani","year":"2010","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1378\/chest.14-0793_bib28","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0735-1097(84)80048-0","article-title":"Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease","volume":"4","author":"Packer","year":"1984","journal-title":"J Am Coll Cardiol"},{"issue":"9288","key":"10.1378\/chest.14-0793_bib29","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.1378\/chest.14-0793_bib30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1378\/chest.14-0793_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Gali\u00e8","year":"2006","journal-title":"Circulation"},{"issue":"9630","key":"10.1378\/chest.14-0793_bib32","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Gali\u00e8","year":"2008","journal-title":"Lancet"},{"issue":"23","key":"10.1378\/chest.14-0793_bib33","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"issue":"9","key":"10.1378\/chest.14-0793_bib34","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1378\/chest.14-0793_bib35","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1378\/chest.14-0793_bib36","first-page":"2894","article-title":"Tadalafil therapy for pulmonary arterial hypertension [published correction appears in Circulation 2011;124(10):e279]","volume":"119","author":"Gali\u00e8","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"10.1378\/chest.14-0793_bib37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1378\/chest.14-0793_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1378\/chest.14-0793_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.healun.2009.09.005","article-title":"Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial","volume":"29","author":"Hiremath","year":"2010","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.1378\/chest.14-0793_bib40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.14-0793_bib41","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1378\/chest.14-0793_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/hrt.57.3.270","article-title":"Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin)","volume":"57","author":"Jones","year":"1987","journal-title":"Br Heart J"},{"issue":"2","key":"10.1378\/chest.14-0793_bib43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0735-1097(97)00187-3","article-title":"Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion","volume":"30","author":"Shapiro","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1378\/chest.14-0793_bib44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","article-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial","volume":"112","author":"Rubin","year":"1990","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1378\/chest.14-0793_bib45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-121-6-199409150-00003","article-title":"Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin","volume":"121","author":"Barst","year":"1994","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1378\/chest.14-0793_bib46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM199801293380501","article-title":"Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension","volume":"338","author":"McLaughlin","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1378\/chest.14-0793_bib47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1183\/09031936.04.00028404","article-title":"Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2","volume":"24","author":"Humbert","year":"2004","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1378\/chest.14-0793_bib48","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-149-8-200810210-00004","article-title":"Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial","volume":"149","author":"Simonneau","year":"2008","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1378\/chest.14-0793_bib49","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","article-title":"Survival in primary pulmonary hypertension: the impact of epoprostenol therapy","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1378\/chest.14-0793_bib50","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1378\/chest.14-0793_bib51","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3899\/jrheum.081277","article-title":"Long term survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol","volume":"36","author":"Badesch","year":"2009","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1378\/chest.14-0793_bib52","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.healun.2011.11.002","article-title":"Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study","volume":"31","author":"Kemp","year":"2012","journal-title":"J Heart Lung Transplant"},{"issue":"14","key":"10.1378\/chest.14-0793_bib53","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.CIR.99.14.1858","article-title":"Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects","volume":"99","author":"Rosenzweig","year":"1999","journal-title":"Circulation"},{"issue":"5","key":"10.1378\/chest.14-0793_bib54","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1164\/ajrccm.162.5.2004042","article-title":"Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension","volume":"162","author":"Aguilar","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.14-0793_bib55","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.510300307","article-title":"Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension","volume":"30","author":"Krowka","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1378\/chest.14-0793_bib56","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1378\/chest.129.3.683","article-title":"Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial","volume":"129","author":"Tapson","year":"2006","journal-title":"Chest"},{"issue":"12","key":"10.1378\/chest.14-0793_bib57","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1164\/rccm.200505-766OC","article-title":"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension","volume":"172","author":"Gomberg-Maitland","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1378\/chest.14-0793_bib58","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1378\/chest.126.1.90","article-title":"Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension","volume":"126","author":"Oudiz","year":"2004","journal-title":"Chest"},{"issue":"8","key":"10.1378\/chest.14-0793_bib59","first-page":"170","article-title":"Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension\u2014seven sites, United States, 2003-2006","volume":"56","author":"Centers for Disease Control and Prevention (CDC)","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1378\/chest.14-0793_bib60","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.mayocp.2012.05.014","article-title":"Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY(R)","volume":"87","author":"Kitterman","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1378\/chest.14-0793_bib61","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/529552","article-title":"Bloodstream infections in patients given treatment with intravenous prostanoids","volume":"29","author":"Kallen","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1378\/chest.14-0793_bib62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1378\/chest.11-0245","article-title":"The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension","volume":"141","author":"Rich","year":"2012","journal-title":"Chest"},{"issue":"12","key":"10.1378\/chest.14-0793_bib63","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.arbres.2012.06.005","article-title":"High incidence of bloodstream infection due to gram-negative bacilli in patients with pulmonary hypertension receiving intravenous treprostinil","volume":"48","author":"L\u00f3pez-Medrano","year":"2012","journal-title":"Arch Bronconeumol"},{"issue":"2","key":"10.1378\/chest.14-0793_bib64","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.126.2.420","article-title":"Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease","volume":"126","author":"Oudiz","year":"2004","journal-title":"Chest"},{"issue":"6","key":"10.1378\/chest.14-0793_bib65","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1378\/chest.129.6.1636","article-title":"Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension","volume":"129","author":"Lang","year":"2006","journal-title":"Chest"},{"issue":"18","key":"10.1378\/chest.14-0793_bib66","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","article-title":"Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial","volume":"55","author":"McLaughlin","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1378\/chest.14-0793_bib67","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1164\/rccm.200603-358OC","article-title":"Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension","volume":"174","author":"McLaughlin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1378\/chest.14-0793_bib68","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.healun.2011.08.019","article-title":"Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension","volume":"30","author":"Benza","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"1_suppl","key":"10.1378\/chest.14-0793_bib69","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1378\/chest.126.1_suppl.35S","article-title":"Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"Badesch","year":"2004","journal-title":"Chest"},{"issue":"1","key":"10.1378\/chest.14-0793_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1753465812461680","article-title":"Pulmonary arterial hypertension in pregnant women","volume":"7","author":"Safdar","year":"2013","journal-title":"Ther Adv Respir Dis"},{"key":"10.1378\/chest.14-0793_bib71","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00006254-196408000-00001","article-title":"Primary pulmonary hypertension in pregnancy","volume":"19","author":"McCaffrey","year":"1964","journal-title":"Obstet Gynecol Surv"},{"issue":"7","key":"10.1378\/chest.14-0793_bib72","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/S0735-1097(98)00162-4","article-title":"Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996","volume":"31","author":"Weiss","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.14-0793_bib73","doi-asserted-by":"crossref","unstructured":"Jais X, Olsson KM, Barbera JA, et al. Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J; 40(4):881-885","DOI":"10.1183\/09031936.00141211"},{"key":"10.1378\/chest.14-0793_bib74","series-title":"Cardiac Problems in Pregnancy","first-page":"183","article-title":"Primary pulmonary hypertension and pregnancy","author":"Elkayam","year":"1998"},{"issue":"6","key":"10.1378\/chest.14-0793_bib75","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1183\/09031936.00139009","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"34","author":"Gali\u00e8","year":"2009","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1378\/chest.14-0793_bib76","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00404-013-2761-8","article-title":"Pregnancy outcome in women with pulmonary arterial hypertension: single-center experience from India","volume":"288","author":"Subbaiah","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1378\/chest.14-0793_bib77","first-page":"149","article-title":"Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report","volume":"45","author":"Badalian","year":"2000","journal-title":"J Reprod Med"},{"issue":"2","key":"10.1378\/chest.14-0793_bib78","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/bja\/87.2.295","article-title":"Primary pulmonary hypertension in pregnancy; a role for novel vasodilators","volume":"87","author":"Monnery","year":"2001","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1378\/chest.14-0793_bib79","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/bja\/81.5.790","article-title":"Anaesthesia for caesarean section in the presence of severe primary pulmonary hypertension","volume":"81","author":"O'Hare","year":"1998","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1378\/chest.14-0793_bib80","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1378\/chest.119.3.973","article-title":"Pregnancy and primary pulmonary hypertension: successful outcome with epoprostenol therapy","volume":"119","author":"Stewart","year":"2001","journal-title":"Chest"},{"issue":"6","key":"10.1378\/chest.14-0793_bib81","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF03016836","article-title":"Use of inhaled nitric oxide for emergency Cesarean section in a woman with unexpected primary pulmonary hypertension","volume":"48","author":"Decoene","year":"2001","journal-title":"Can J Anaesth"},{"issue":"5 pt 2","key":"10.1378\/chest.14-0793_bib82","first-page":"895","article-title":"Inhaled nitric oxide for primary pulmonary hypertension in pregnancy","volume":"98","author":"Lam","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1378\/chest.14-0793_bib83","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0002-9378(99)70686-1","article-title":"Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension","volume":"180","author":"Robinson","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1378\/chest.14-0793_bib84","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0002-9378(95)90047-0","article-title":"Primary pulmonary hypertension in pregnancy: a case report","volume":"172","author":"Kiss","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1378\/chest.14-0793_bib85","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/BF03011545","article-title":"Pulmonary hypertension and pregnancy: a series of eight cases","volume":"41","author":"Smedstad","year":"1994","journal-title":"Can J Anaesth"},{"issue":"2","key":"10.1378\/chest.14-0793_bib86","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1399-6576.2001.450220.x","article-title":"Cesarean section under epidural ropivacaine 0.75% in a parturient with severe pulmonary hypertension","volume":"45","author":"Olofsson","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"issue":"4","key":"10.1378\/chest.14-0793_bib87","doi-asserted-by":"crossref","first-page":"282","DOI":"10.7326\/0003-4819-143-4-200508160-00009","article-title":"Evaluation and management of the patient with pulmonary arterial hypertension","volume":"143","author":"Rubin","year":"2005","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1378\/chest.14-0793_bib88","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1378\/chest.11-2016","article-title":"Effects of commercial air travel on patients with pulmonary hypertension air travel and pulmonary hypertension","volume":"142","author":"Roubinian","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.14-0793_bib89","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.rmed.2012.10.007","article-title":"Hypoxaemia in patients with pulmonary arterial hypertension during simulated air travel","volume":"107","author":"Burns","year":"2013","journal-title":"Respir Med"},{"issue":"6","key":"10.1378\/chest.14-0793_bib90","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1183\/09031936.00089212","article-title":"Outcomes of\u00a0noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey","volume":"41","author":"Meyer","year":"2013","journal-title":"Eur Respir J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215488348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215488348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:23:56Z","timestamp":1757921036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215488348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0012369215488348"],"URL":"https:\/\/doi.org\/10.1378\/chest.14-0793","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.14-0793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1378\/chest.14-1440","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1378\/chest.14-0527","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}